Application

17280467 · CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) AND CD22 CAR COMBINATION THERAPIES

Filed 2021-03-26 · Abandoned The official file ↗ · Art unit 1633 · Examiner Masudur Rahman Easy · CPC C07K2319/03 · The Trustees of the University of Pennsylvania · K&L Gates - Novartis

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

18.9 mo

to disposition 46.9 mo

Statutes raised

103

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.